Nothing Special   »   [go: up one dir, main page]

ATE405582T1 - P53 bindende t-zellrezeptormoleküle und deren verwendungen - Google Patents

P53 bindende t-zellrezeptormoleküle und deren verwendungen

Info

Publication number
ATE405582T1
ATE405582T1 AT02746470T AT02746470T ATE405582T1 AT E405582 T1 ATE405582 T1 AT E405582T1 AT 02746470 T AT02746470 T AT 02746470T AT 02746470 T AT02746470 T AT 02746470T AT E405582 T1 ATE405582 T1 AT E405582T1
Authority
AT
Austria
Prior art keywords
molecules
protein
tcr
cell receptor
binding
Prior art date
Application number
AT02746470T
Other languages
English (en)
Inventor
Linda Sherman
Kimberlyn Card
Jon Weidanz
Hing Wong
Elizabeth Thomson
Original Assignee
Altor Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altor Bioscience Corp filed Critical Altor Bioscience Corp
Application granted granted Critical
Publication of ATE405582T1 publication Critical patent/ATE405582T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02746470T 2001-06-05 2002-06-05 P53 bindende t-zellrezeptormoleküle und deren verwendungen ATE405582T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29632401P 2001-06-05 2001-06-05

Publications (1)

Publication Number Publication Date
ATE405582T1 true ATE405582T1 (de) 2008-09-15

Family

ID=31946570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746470T ATE405582T1 (de) 2001-06-05 2002-06-05 P53 bindende t-zellrezeptormoleküle und deren verwendungen

Country Status (11)

Country Link
US (1) US7456263B2 (de)
EP (2) EP2009019A1 (de)
JP (1) JP4447456B2 (de)
CN (1) CN1692124B (de)
AT (1) ATE405582T1 (de)
AU (1) AU2002316190B8 (de)
CA (1) CA2487779C (de)
DE (1) DE60228504D1 (de)
DK (1) DK1546188T3 (de)
ES (1) ES2307770T3 (de)
WO (1) WO2004018619A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1289564B1 (de) * 2000-06-05 2018-07-18 Altor BioScience Corporation T-zell-rezeptor fusionen und konjugate und verfahren zu deren verwendung
CA2544483C (en) 2003-11-10 2013-09-10 Altor Bioscience Corporation Soluble tcr fusion molecules and methods of use
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
EP2486049A1 (de) 2009-10-06 2012-08-15 The Board Of Trustees Of The UniversityOf Illinois Menschliche einkettige t-zell-rezeptoren
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
US9181527B2 (en) 2009-10-29 2015-11-10 The Trustees Of Dartmouth College T cell receptor-deficient T cell compositions
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
JP6389166B2 (ja) 2012-05-07 2018-09-12 トラスティーズ・オブ・ダートマス・カレッジ 抗ｂ７−ｈ６抗体、融合タンパク質、及びこれらを使用する方法
UA114108C2 (uk) 2012-07-10 2017-04-25 Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
BR112020006012A2 (pt) * 2017-09-29 2020-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services receptores de células t que reconhecem p53 mutado
US20200308279A1 (en) 2017-10-06 2020-10-01 Oslo Universitetssykehus Hf Chimeric antigen receptors
CN108060135A (zh) * 2017-12-26 2018-05-22 东莞赛尔生物科技有限公司 一种高效表达p53抑癌蛋白的t细胞、制备方法及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US5057313A (en) * 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
WO1988007553A1 (en) * 1987-03-26 1988-10-06 Teijin Limited Process for preparing antibody complex
AU656518B2 (en) * 1990-02-20 1995-02-09 Coulter Corporation Improved antibody-enzyme direct conjugates and method of making same
GB9200417D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Cytotoxic drug therapy
US6399368B1 (en) * 1992-01-17 2002-06-04 Board Of Regents, The University Of Texas System Secretion of T cell receptor fragments from recombinant Escherichia coli cells
ATE183514T1 (de) 1992-05-26 1999-09-15 Univ Leiden Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
DK0776339T4 (da) 1994-07-29 2010-05-25 Sunol Molecular Corp MHC-komplekser og anvendelser deraf
WO1996013593A2 (en) 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
AU712441B2 (en) * 1994-12-14 1999-11-04 Scripps Research Institute, The In vivo activation of tumor-specific cytotoxic T cells
US5830755A (en) * 1995-03-27 1998-11-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services T-cell receptors and their use in therapeutic and diagnostic methods
US5869270A (en) 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
WO1997032603A1 (en) 1996-03-05 1997-09-12 The Scripps Research Institute Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6127524A (en) 1996-10-18 2000-10-03 Dade Behring Inc. Binding molecules and computer-based methods of increasing the binding affinity thereof
EP0977886A4 (de) 1997-03-07 2002-10-23 Sunol Molecular Corp Fusionsproteine, welche ein bakteriophagen-hüllprotein sowie einen einzelketten t-zell-rezeptor enthalten
CA2305630C (en) 1997-10-02 2012-11-06 Sunol Molecular Corporation Soluble single-chain t-cell receptor proteins
DK1124568T3 (da) 1998-10-21 2008-01-02 Altor Bioscience Corp Polyspecifikke bindingsmolekyler og anvendelser deraf
JP2004501364A (ja) 2000-05-25 2004-01-15 スノル・モレキュラー・コーポレーション Ｔ−細胞レセプター相互作用のモジュレーション
EP1289564B1 (de) 2000-06-05 2018-07-18 Altor BioScience Corporation T-zell-rezeptor fusionen und konjugate und verfahren zu deren verwendung
DE10109855A1 (de) * 2001-03-01 2002-09-12 Stanislawski Thomas Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung

Also Published As

Publication number Publication date
ES2307770T3 (es) 2008-12-01
US20080269113A1 (en) 2008-10-30
WO2004018619A3 (en) 2005-05-06
WO2004018619A2 (en) 2004-03-04
EP1546188B1 (de) 2008-08-20
AU2002316190A8 (en) 2004-04-08
EP1546188A2 (de) 2005-06-29
AU2002316190B2 (en) 2009-01-22
DE60228504D1 (de) 2008-10-02
US7456263B2 (en) 2008-11-25
DK1546188T3 (da) 2008-10-27
CA2487779A1 (en) 2004-03-04
JP4447456B2 (ja) 2010-04-07
AU2002316190B8 (en) 2009-01-29
EP2009019A1 (de) 2008-12-31
CA2487779C (en) 2012-10-02
JP2005525128A (ja) 2005-08-25
CN1692124A (zh) 2005-11-02
EP1546188A4 (de) 2005-12-21
AU2002316190A1 (en) 2004-03-17
CN1692124B (zh) 2012-05-30

Similar Documents

Publication Publication Date Title
ATE370967T1 (de) Polyspezifische bindemoleküle und deren verwendung
DE69730693D1 (de) Mhc-komplexe und ihre verwendungen
ATE406906T1 (de) Von survivin abstammende peptide und deren verwendung
ATE405582T1 (de) P53 bindende t-zellrezeptormoleküle und deren verwendungen
ATE533784T1 (de) Lösliche, einzelkettige proteine des t- zellrezeptors
CY1108083T1 (el) Αντιγονα και συνθεσεις του neisseria meningitidis
EP1724282A3 (de) Verfahren zur Herstellung von nicht-immunogenen Proteinen
CY1107881T1 (el) Τροποποιημενα πεπτιδια ως θεραπευτικοι παραγοντες
CY1110848T1 (el) Αντισωμα αντι ανθρωπου νοgo α kai h φαρμακευτικη του χρηση
NO20034588L (no) Materialer og metoder for anvendelse av HLA-DQ-restringerte T- cellereseptorer og HLA-DQ-bindende prolaminderiverte peptider
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE207459T1 (de) O-malonyltyrosyl-verbindungen, o-malonyltyrosyl- verbindungen enthaltende peptide und ihre verwendung
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
ATE336579T1 (de) Isolierte mhc-klasse ii-bindende peptide, und deren verwendung
DK1622929T3 (da) Apo-2L (TRAIL) receptorbindingspeptider og anvendelser deraf
MXPA02005236A (es) Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos.
CA2270877A1 (en) Peptide-based immunotherapeutic agent
WO2003104259A3 (en) PEPTIDES PRESENTED BY HLA-B18 AND HLA-CW16 MOLECULES AND USES OF SUCH PEPTIDES

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1546188

Country of ref document: EP